Epidoxoform: A hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells
Journal Article
Overview
publication date
- April 9, 1998
has subject area
- Aminoglycosides - Doxorubicin
- Aminoglycosides - Epirubicin
- Antibiotics, Antineoplastic
- Biochemical Phenomena - Kinetics
- Cell Cycle - Cell Division
- Cell Physiological Phenomena - Cell Division
- DNA - DNA Adducts
- DNA Damage - DNA Adducts
- Diagnostic Techniques and Procedures - Drug Screening Assays, Antitumor
- Drug Resistance, Neoplasm
- Genetic Phenomena - Cell Division
- Growth - Cell Division
- Humans
- Hydrocarbons, Aromatic - Doxorubicin
- Hydrocarbons, Aromatic - Epirubicin
- Hydrogen-Ion Concentration
- Hydrolysis
- Investigative Techniques - Drug Screening Assays, Antitumor
- Investigative Techniques - Drug Screening Assays, Antitumor
- Investigative Techniques - Drug Screening Assays, Antitumor
- Magnetic Resonance Spectroscopy
- Mass Spectrometry
- Mechanical Phenomena - Kinetics
- Oligonucleotides
- Polycyclic Compounds - Doxorubicin
- Polycyclic Compounds - Epirubicin
- Tumor Cells, Cultured
has restriction
- closed
Date in CU Experts
- September 3, 2013 2:59 AM
Full Author List
- Taatjes DJ; Fenick DJ; Koch TH
author count
- 3
citation count
- 25
published in
- Journal of Medicinal Chemistry Journal
Other Profiles
International Standard Serial Number (ISSN)
- 0022-2623
Digital Object Identifier (DOI)
Additional Document Info
start page
- 1306
end page
- 1314
volume
- 41
issue
- 8